Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.19
Delayed Data
As of 4:00pm ET
 +0.15 / +2.98%
Today’s Change
3.92
Today|||52-Week Range
8.38
+11.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-86.5M-23.5M-30.4M-21.9M
 
 
 
 
 
Depreciation230.0K230.0K248.0K252.0K
 
 
 
 
 
Total Other Cash Flow66.5M4.6M9.3M7.7M
 
 
 
 
 
Funds From Operations-19.8M-18.6M-21.2M-14.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.6M10.6M-989.0K18.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-18.2M-29.2M-20.2M-33.4M
 
 
 
 
 
 
InvestingCapital Expenditures-420.0K-756.0K-81.0K-78.0K
 
 
 
 
 
Net Cash Flow Investing-420.0K-756.0K-81.0K-78.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale68.2M3.4M86.0K69.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.00302.0K0.00
 
 
Net Cash Flow - Financing68.2M3.4M-216.0K69.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash49.6M-26.5M-20.5M-33.4M